Main > NEUROLOGY. > Batten Disease > Treatment > Co: USA. B. Cerliponase Alfa

---

Co: USA. B. Cerliponase Alfa's subsections
(*) EU Approval Date: 2017. 06.01.
(*) USA Approval Date: 2017. 04.27.
Ceroid LipofusciNosis type 2 (CLN2)
Company
Pediatrics
TradeMark
TradeMark WEb-Site
TriPeptidyl Peptidase 1 (TPP1)>
UpDate: 2017. 06.02

Co: USA. B. Cerliponase Alfa's products
This section has no products